Cargando…

Detection of HIV Virologic Failure and Switch to Second-Line Therapy: A Systematic Review and Meta-analysis of Data From Sub-Saharan Africa

BACKGROUND: The late recognition of virologic failure (VF) places persons with HIV in Sub-Saharan Africa at risk for HIV transmission, disease progression, and death. We conducted a systematic review and meta-analysis to determine if the recognition and response to VF in the region has improved. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernabé, Kerlly J, Siedner, Mark, Tsai, Alexander C, Marconi, Vincent C, Murphy, Richard A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007921/ https://www.ncbi.nlm.nih.gov/pubmed/35434173 http://dx.doi.org/10.1093/ofid/ofac121

Ejemplares similares

Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps
por: Murphy, Richard A., et al.
Publicado: (2017)

The Missing Men: HIV Treatment Scale-Up and Life Expectancy in Sub-Saharan Africa
por: Tsai, Alexander C., et al.
Publicado: (2015)

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure
por: Shroufi, Amir, et al.
Publicado: (2019)

Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa — A Systematic Review and Meta-Analysis
por: Madec, Yoann, et al.
Publicado: (2013)

Sonography to Rule Out Tuberculosis in Sub-Saharan Africa: A Prospective Observational Study
por: Ndege, Robert, et al.
Publicado: (2019)

Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis
por: Edessa, Dumessa, et al.
Publicado: (2019)

Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study
por: Siedner, Mark J, et al.
Publicado: (2019)

Correction: Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa — A Systematic Review and Meta-Analysis
Publicado: (2014)

Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile
por: Phillips, Andrew N., et al.
Publicado: (2016)

Correction: Second-line HIV treatment failure in sub-Saharan Africa: A systematic review and meta-analysis
Publicado: (2019)

Heart Failure in Sub-Saharan Africa
por: Bloomfield, Gerald S, et al.
Publicado: (2013)

Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis
por: Nachega, Jean B, et al.
Publicado: (2022)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
por: Phillips, Andrew N., et al.
Publicado: (2016)

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa
por: Kityo, Cissy, et al.
Publicado: (2017)

Prevalence and predictors of virological failure in pediatric patients on HAART in sub-Saharan Africa: a systematic review and meta-analysis
por: Machila, Nchimunya, et al.
Publicado: (2023)

Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa
por: Schoffelen, Annelot F., et al.
Publicado: (2013)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2017)

Data on the epidemiology of heart failure in Sub-Saharan Africa
por: Nyaga, Ulrich Flore, et al.
Publicado: (2018)

Transmission of Cryptosporidium Species Among Human and Animal Local Contact Networks in Sub-Saharan Africa: A Multicountry Study
por: Krumkamp, Ralf, et al.
Publicado: (2020)

To fast or not to fast: Lipid measurement and cardiovascular disease risk estimation in rural sub-Saharan Africa
por: Yang, Isabelle T, et al.
Publicado: (2020)

The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania
por: Ramadhani, Habib O., et al.
Publicado: (2016)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Optimizing Network Connectivity for Mobile Health Technologies in sub-Saharan Africa
por: Siedner, Mark J., et al.
Publicado: (2012)

Prices of second-line antiretroviral treatment for middle-income countries inside versus outside sub-Saharan Africa
por: Simmons, Bryony, et al.
Publicado: (2014)

Vaccinology in sub-Saharan Africa
por: Moïsi, Jennifer, et al.
Publicado: (2019)

Depression in Sub-Saharan Africa
por: Gbadamosi, Ismail Temitayo, et al.
Publicado: (2022)

Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study
por: Isfordink, Cas, et al.
Publicado: (2022)

Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
por: Collier, Dami, et al.
Publicado: (2017)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria
por: Schmitt, Esther K, et al.
Publicado: (2021)

Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries
por: McMorrow, Meredith L., et al.
Publicado: (2015)

Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy
por: Kroeze, Stefanie, et al.
Publicado: (2019)

Factors Associated With Peripartum Virologic Suppression in Eastern Cape Province, South Africa: A Retrospective Cross-Sectional Analysis
por: Adeniyi, Oladele Vincent, et al.
Publicado: (2021)

Water, Sanitation, and Cholera in Sub-Saharan Africa
por: Sikder, Mustafa, et al.
Publicado: (2023)

Harnessing Poverty Alleviation to Reduce the Stigma of HIV in Sub-Saharan Africa
por: Tsai, Alexander C., et al.
Publicado: (2013)

Effects of the Coronavirus Disease 2019 Pandemic on Human Immunodeficiency Virus Services: Findings from 11 Sub-Saharan African Countries
por: Harris, Tiffany G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lvbvr46d9o2hkgtk0kqv0ssueo